Literature DB >> 16514345

Prevention of tuberculosis in HIV-infected patients.

Payam Nahid1, Charles L Daley.   

Abstract

PURPOSE OF REVIEW: The pandemic of HIV infection has contributed to a significant increase in tuberculosis rates worldwide. Tuberculosis is one of the most common opportunistic infections in HIV-infected patients, and the leading cause of death. In order to control tuberculosis in areas with high rates of co-infection, strategies must be developed to prevent tuberculosis in HIV-infected individuals. RECENT
FINDINGS: Recent reviews have highlighted the burden of HIV-related tuberculosis in the world and the necessary steps that must be taken to control tuberculosis in certain high-risk regions like sub-Saharan Africa. The Centers for Disease Control and Prevention has recently published guidelines for the use of the diagnostic test QuantiFERON-TB Gold, and cautioned about interpretation of this test in HIV-infected patients because of a lack of information regarding performance in these individuals. Perhaps the most significant studies over the past year have reported the impact that treating HIV infection can have on the risk of tuberculosis.
SUMMARY: HIV and tuberculosis continue to be linked in a global pandemic. In addition to the standard approaches to tuberculosis control, such as the diagnosis and treatment of tuberculosis and latent tuberculosis infection, recent studies have demonstrated that treatment of HIV itself may also have a role in tuberculosis control.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16514345     DOI: 10.1097/01.qco.0000216631.36316.62

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  5 in total

1.  Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced disease.

Authors:  S A Clark; S L Martin; A Pozniak; A Steel; B Ward; J Dunning; D C Henderson; M Nelson; B Gazzard; P Kelleher
Journal:  Clin Exp Immunol       Date:  2007-08-02       Impact factor: 4.330

2.  How dormant is Mycobacterium tuberculosis during latency? A study integrating genomics and molecular epidemiology.

Authors:  Zhenhua Yang; Mariana Rosenthal; Noah A Rosenberg; Sarah Talarico; Lixin Zhang; Carl Marrs; Vibeke Østergaard Thomsen; Troels Lillebaek; Aase B Andersen
Journal:  Infect Genet Evol       Date:  2011-02-18       Impact factor: 3.342

3.  Synthesis of deoxygenated alpha(1-->5)-linked arabinofuranose disaccharides as substrates and inhibitors of arabinosyltransferases of Mycobacterium tuberculosis.

Authors:  Ashish K Pathak; Vibha Pathak; William J Suling; James R Riordan; Sudagar S Gurcha; Gurdyal S Besra; Robert C Reynolds
Journal:  Bioorg Med Chem       Date:  2008-11-18       Impact factor: 3.641

Review 4.  Autophagy in immunity against mycobacterium tuberculosis: a model system to dissect immunological roles of autophagy.

Authors:  Vojo Deretic; Monica Delgado; Isabelle Vergne; Sharon Master; Sergio De Haro; Marisa Ponpuak; Sudha Singh
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

Review 5.  DNA Replication in Mycobacterium tuberculosis.

Authors:  Zanele Ditse; Meindert H Lamers; Digby F Warner
Journal:  Microbiol Spectr       Date:  2017-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.